Peter A. Johansson
Researcher Next ID · RN-025356
Researcher · Biochemistry, Genetics and Molecular Biology
Queensland University of Technology
Brisbane, Brazil
- Works count
- 311
- Citation count
- 31,307
- H-index
- 60
- i10-index
- 121
Research interests
Publications
The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58
Diabetes Care · 2021 · https://doi.org/10.2337/dc21-0076
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
The Lancet Diabetes & Endocrinology · 2019 · https://doi.org/10.1016/s2213-8587(19)30180-9
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Circulation · 2019 · https://doi.org/10.1161/circulationaha.119.040130
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-11107-x
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Circulation · 2019 · https://doi.org/10.1161/circulationaha.119.042685
Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE–TIMI 58 Study
Diabetes Care · 2019 · https://doi.org/10.2337/dc19-1476
DECLARE‐TIMI 58: Participants’ baseline characteristics
Diabetes Obesity and Metabolism · 2018 · https://doi.org/10.1111/dom.13217
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1812389
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
American Heart Journal · 2018 · https://doi.org/10.1016/j.ahj.2018.01.012
Whole-genome landscapes of major melanoma subtypes
Nature · 2017 · https://doi.org/10.1038/nature22071
POT1 loss-of-function variants predispose to familial melanoma
Nature Genetics · 2014 · https://doi.org/10.1038/ng.2947
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
Nature Communications · 2014 · https://doi.org/10.1038/ncomms6694
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
Proceedings of the National Academy of Sciences · 2007 · https://doi.org/10.1073/pnas.0702507104
Current projects
No projects listed.